What is NDC 55111-404?

55111-404 is the product NDC for Ranitidine, Ranitidine hydrochloride 150 mg/1 tablet, coated, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 14 package NDCs, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranitidine?

12 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranitidine NDC 55111-404 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-404Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0404Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-404-02	5511104040255111040402	1 BOTTLE in 1 CARTON (55111-404-02) / 200 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-17	5511104041755111040417	1 BLISTER PACK in 1 CARTON (55111-404-17) / 8 TABLET, COATED in 1 BLISTER PACKMarketed from Dec 2, 2009
55111-404-24	5511104042455111040424	3 BLISTER PACK in 1 CARTON (55111-404-24) / 8 TABLET, COATED in 1 BLISTER PACKMarketed from Dec 2, 2009
55111-404-32	5511104043255111040432	1 BOTTLE in 1 CARTON (55111-404-32) / 32 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-34	5511104043455111040434	1 BOTTLE in 1 CARTON (55111-404-34) / 24 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-36	5511104043655111040436	1 BOTTLE in 1 CARTON (55111-404-36) / 36 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-38	5511104043855111040438	4 BLISTER PACK in 1 CARTON (55111-404-38) / 8 TABLET, COATED in 1 BLISTER PACKMarketed from Dec 2, 2009
55111-404-40	5511104044055111040440	1 BOTTLE in 1 BOTTLE (55111-404-40) / 40 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-50	5511104045055111040450	1 BOTTLE in 1 CARTON (55111-404-50) / 50 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-55	5511104045555111040455	2 BOTTLE in 1 CARTON (55111-404-55) / 65 TABLET, COATED in 1 BOTTLEMarketed from Jan 5, 2010
55111-404-61	5511104046155111040461	1 BOTTLE in 1 CARTON (55111-404-61) / 65 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-62	5511104046255111040462	1 BOTTLE in 1 CARTON (55111-404-62) / 95 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-65	5511104046555111040465	1 BOTTLE in 1 CARTON (55111-404-65) / 220 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009
55111-404-90	5511104049055111040490	2 BOTTLE in 1 CARTON (55111-404-90) / 95 TABLET, COATED in 1 BOTTLEMarketed from Dec 2, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranitidine
Generic name (nonproprietary): ranitidine
Active ingredients: Ranitidine hydrochloride — 150 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Dr. Reddy's Laboratories LimitedNDC labeler code 55111
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078192
Marketing start: Dec 2, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55111-404_c47f1d10-c4d9-5df4-84e8-55956b47568bSPL ID c47f1d10-c4d9-5df4-84e8-55956b47568bSPL set ID 00df8a42-296f-80dd-98af-ee8b30eb38ccRxCUI 198191UNII BK76465IHM
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111040402 followed by a unit qualifier and the quantity

Package 55111-0404-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 23, 2025.

Indications (excerpt from the label)

Use(s) relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-404

What is NDC 55111-404?: 55111-404 is the product NDC for Ranitidine, Ranitidine hydrochloride 150 mg/1 tablet, coated, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 14 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranitidine.
What is the active ingredient?: Ranitidine hydrochloride.
Who is the labeler?: Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranitidine?: 12 other product NDCs are listed under this name. See all Ranitidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranitidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-314	71993-0314-30
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Atland Pharmaceuticals, LLC	71993-315	71993-0315-30
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-636	64980-0636-03
Ranitidine	Ranitidine hydrochloride 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-637	64980-0637-03
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Granules India Ltd	62207-773	62207-0773-3662207-0773-4162207-0773-47+1 more
Ranitidine	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-109	27241-0109-0627241-0109-50
Ranitidine	Ranitidine hydrochloride 300 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-110	27241-0110-0327241-0110-10
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-0727	00121-0727-16
Ranitidine	Ranitidine 15 mg/mL	SyrupOral	Pharmaceutical Associates, Inc.	0121-4727	00121-4727-10
Ranitidine	Ranitidine hydrochloride 150 mg/1	TabletOral	Amneal Pharmaceuticals of New York LLC	53746-253	53746-0253-0153746-0253-0553746-0253-10+2 more

All 13 Ranitidine NDCs